´óÏóÊÓÆµ

Intestinal Parasites

  • Parasites

    Findings

    Investigate

    Treatment alternatives

    Family

    Follow-up

    Repeat treatment


    Amoebiasis

    Trophozoites or cysts on stool micro (cannot distinguish between cysts of E. histolytica/dispar/ moshkovskii). Multiplex PCR distinguishes spp

    May be associated with GIT symptoms, including colitis

    FBE/differential

    Fresh stool <24 h for ELISA or PCR if available. If E dispar confirmed - nothing. If E histolytica confirmed treat.

    If ELISA/PCR not available, serology (IHA) for E. histolytica, although baseline positive 30% endemic areas.

    Asymptomatic: eliminate intraluminal carriage

    Paramomycin 10mg/kg/dose (max 500mg) 8 hourly oral 7 days (SAS medication)

    Symptomatic: Discuss with ID. Metronidazole 15mg/kg/dose (max 600mg) tds oral 7 days followed by luminal agent (as above). Higher doses in severe disease/confirmed liver abscess.

    Offer screen Discuss with ID physicians if symptomatic As required for parasite persistence or reinfection

    Ova on stool micro

    History macroscopic worms

    May be a/w respiratory symptoms

    FBE/differential

    Albendazole (weight >10kg) 400mg oral stat (200mg oral stat if >6 months, <10kg)

    Mebendazole 100mg oral bd 3 days (50mg oral bd 3 days if <10kg)

    Offer screen, Rx siblings Repeat stool micro at follow-up (not essential) As required for parasite persistence or reinfection

    Trophozoites or cysts on stool micro

    May be associated with GIT symptoms.ÌýAsymptomatic carriage in immune competent may not need treatment.

    nil

    Metronidazole 30mg/kg (max 2g) oral daily for 3 days OR 10mg/kg (max 400mg) oral 8-hourly for 3 days

    TinidazoleÌýdiscontinued in 2020. Nitazoxanide, albendazole, mebendazole or paromomycin are alternatives

    Screen symptomatic family Repeat stool micro at follow-up (not essential) As required for parasite persistence or reinfection
    Ancylostoma or Necator Ova on stool micro

    FBE/differential

    Ferritin

    Albendazole (weight >10 kg) 400mg oral stat (200mg oral stat if >6 months, <10kg)

    MebendazoleÌý100mg oral bd 3 days (50mg oral bd 3 days if <10kg)

    Offer screen Repeat stool micro at follow-up As required for parasite persistence or reinfection

    (Risk of dissemination if immune suppressed)

    See guideline

    Strongyloides serology is primary screen

    Larvae on stool micro

    Strongyloides serology

    FBE/differential

    Ivermectin (weight >15 kg) 200mcg/kg (no upper limit) x 2 doses, day 1 and day 14 (2 weeks apart). More doses if immunocompromised

    Albendazole (weight >10 kg) 400mg oral bd for 3 days + repeat course after 14 days (200mg oral bd as above if >6 months, <10kg) less effective than ivermectin

    Offer screen

    If larvae on stool micro then repeat 3 days post treatment

    Serology & FBE at 6 months

    If parasites persist on stool micro

    If serum IgG & eosinophilia persist at 3-6 months

    Children <15kg may require monitoring & Rx with ivermectin once 15kg

    Clear positive IgG

    Fresh stool micro

    FBE/differential

    Pulmonary or GIT symptoms Discuss with ID consultant urgently


    (Bilharzia)

    see guideline

    Schistosoma serology is primary screen (more sensitive for S. mansoni & S. haematobium than others)

    Ova on stool micro

    FBE/differential



    PraziquantelÌý20mg/kg x 2 doses oral, 4 hrs apart (no upper limit)Ìý

    40mg/kg total may be given as a stat dose in children

      Offer screen

      If initial stool or urine micro+ repeat at 3-6 months (x 3 specimens)

      FBE/differential at 3 months

      Serology at 12 months

      Persistent parasite, increasing IgG titre 6 months post Rx (especially if eosinophillia)

      IgG same at 12mo

      If positive serology - check stool COP and end urine

      If positive stool or urine, further investigations for end-organ damage

      Midday end urine micro for ova (lab x5738 first)

      Renal/bladder US (urinary) or liver US & doppler (gut)

      Tapeworm
      (pig) or (beef)

      Proglottids or ova in faeces

      Nodules

      Check neurological symptoms/epilepsy Hx (T. solium,Ìýdifferent Rx)

      FBE/differential

      Ferritin

      Praziquantel 10mg/kg oral stat (no upper limit)

      NiclosamideÌý50mg/kg (max 2g) oral stat

      (Rodentolepis) nanaÌý(dwarf tapeworm) - Praziquantal 25mg/kg oral stat (no upper limit)

      Offer screen Repeat stool micro at 3 weeks - not essential. As required for parasite persistence or reinfection
      Trichuris trichiuria

      Ova stool micro

      May be associated with bloody diarrhoea, pain or rectal prolapse

      FBE/differential

      Ferritin

      Mebendazole 100mg oral bd 3 days (50mg oral bd 3 days weight <10kg)

      Albendazole 400mg oral daily for 3 days (200mg oral daily for 3 days >6m, weight <10kg)

      Offer screen Repeat stool micro at 3 weeks - not essential As required for parasite persistence or reinfection

      Note:

      1. - Australian guidelines now providing dosing for children 1-18y (although limited evidence <4 years, some trials age 2-5 years) - discuss with Infectious diseases for younger children. for children >5kg - (150mg dispersible tablets)
      2. Albendazole tabs are chewable and soluble, in children 12 months - 12 years (as annual or biannual 400mg dose) where baseline prevalence of soil transmitted infection is 20%+. Biannual dosing recommended if baseline prevalence is >50%. Discuss if liver disease
      3. Ivermectin is used in children >15 kg
      4. Exclude pregnancy in adolescents; Praziquantal B1, Metronidazole B2, Ivermectin B3, Albendazole D.

      Background

      Parasite infections are common; prevalence figures for presence of faecal parasites in post arrival refugee health screening in Australia are generally around 30% - see Ìýprevalence summary. Macroscopic worms are very rare, but if reported, are likely Ascaris and Taenia spp.4ÌýAscarids may be seen again in new arrivals from Gaza.

      Symptoms are relatively common and include both diarrhoea and constipation as a presenting complaint. Our clinical experience is that many patients have been 'retrospectively' symptomatic - reporting resolution of grumbling abdominal pain and solid stool for the first time after parasite treatment. In a , 39.8% had any parasites, 26.8% had faecal pathogens, and 78.5% of all faecal specimens were noted to be unformed. We have definitely seenÌýTrichurisÌýpresenting with rectal prolapse (and would always check faecal COP for this aetiology if this is a presenting concern). Specific serology is available for Strongyloides, Schistosoma, Filariasis, Echinococcus, Toxocariasis, Angiostrongyliasis,4 Entamoeba histolytica and Taenia spp. Please see separate guidelines for malaria (statewide CPG), malaria screening,ÌýSchistosoma and StrongyloidesÌýinfections, and the superb , including . Seek specialist advice for complicated parasite infections, including hydatid disease, liver abscess, liver flukes, leishmaniasis and others.ÌýÌý

      Non-pathogenic parasites that may be found in stool (no action needs to be taken for these):

      • (Note: rarely implicated as a pathogen, discuss with ID if symptomatic and repeated specimens high growth)
      • (Note: rarely implicated as a pathogen, discuss with ID if symptomatic and repeated specimens high growth)

      Resources

      • , includingÌý
      • eTG - , , .

      References

      Immigrant health clinic resources. Authors: Jim Buttery and Georgie Paxton, updated March 2013, reviewed Jan 2024. Contact georgia.paxton@rch.org.au